Unknown

Dataset Information

0

Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity.


ABSTRACT: Compared with normal differentiated cells, cancer cells upregulate the expression of pyruvate kinase isozyme M2 (PKM2) to support glycolytic intermediates for anabolic processes, including the synthesis of nucleic acids, amino acids, and lipids. In this study, a combination of the structure-based pharmacophore modeling and a hybrid protocol of virtual screening methods comprised of pharmacophore model-based virtual screening, docking-based virtual screening, and in silico ADMET (absorption, distribution, metabolism, excretion and toxicity) analysis were used to retrieve novel PKM2 activators from commercially available chemical databases. Tetrahydroquinoline derivatives were identified as potential scaffolds of PKM2 activators. Thus, the hybrid virtual screening approach was applied to screen the focused tetrahydroquinoline derivatives embedded in the ZINC database. Six hit compounds were selected from the final hits and experimental studies were then performed. Compound 8 displayed a potent inhibitory effect on human lung cancer cells. Following treatment with Compound 8, cell viability, apoptosis, and reactive oxygen species (ROS) production were examined in A549 cells. Finally, we evaluated the effects of Compound 8 on mice xenograft tumor models in vivo. These results may provide important information for further research on novel PKM2 activators as antitumor agents.

SUBMITTER: Chen C 

PROVIDER: S-EPMC4159224 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity.

Chen Can C   Wang Ting T   Wu Fengbo F   Huang Wei W   He Gu G   Ouyang Liang L   Xiang Mingli M   Peng Cheng C   Jiang Qinglin Q  

Drug design, development and therapy 20140902


Compared with normal differentiated cells, cancer cells upregulate the expression of pyruvate kinase isozyme M2 (PKM2) to support glycolytic intermediates for anabolic processes, including the synthesis of nucleic acids, amino acids, and lipids. In this study, a combination of the structure-based pharmacophore modeling and a hybrid protocol of virtual screening methods comprised of pharmacophore model-based virtual screening, docking-based virtual screening, and in silico ADMET (absorption, dist  ...[more]

Similar Datasets

| S-EPMC7352364 | biostudies-literature
| S-EPMC3711671 | biostudies-literature
| S-EPMC5715358 | biostudies-literature
| S-EPMC2673266 | biostudies-literature
| S-EPMC2878009 | biostudies-literature
| S-EPMC8632069 | biostudies-literature
| S-EPMC2874658 | biostudies-literature
| S-EPMC4446733 | biostudies-literature
| S-EPMC2818804 | biostudies-other
| S-EPMC6157015 | biostudies-literature